News | Coronavirus (COVID-19) | January 03, 2022

FDA Contraindicates Janssen COVID Vaccine for People With Previous Thrombosis With Thrombocytopenia 

FDA Contraindicates Janssen COVID Vaccine for People With Previous Thrombosis With Thrombocytopenia. #COVID19 #COVIDvaccine

January 3, 2022 — The U.S. Food and Drug Administration (FDA) recently revised its Janssen COVID-19 Vaccine Fact Sheets with a contraindication for any individuals with a history of thrombosis with thrombocytopenia following the Janssen COVID-19 vaccine or any other adenovirus-vectored COVID-19 vaccine.

The fact sheets now include updated information about the risk of thrombosis with thrombocytopenia syndrome (TTS) following vaccination. The updates Occurred December 14.

Cases of thrombosis with thrombocytopenia following administration of the Janssen COVID-19 vaccine have been reported in males and females 18 years of age and older. The highest reporting rate of approximately one case per 100,000 doses administered in females 30-49 years of age. Overall, the FDA said approximately 1 out of 7 cases has been fatal. 

The FDA and Centers for Disease Control and Prevention (CDC) said they continue to investigate the level of potential excess risk. The FDA said it continues to find that the known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older. 

The FDA said individuals should speak to their healthcare provider to determine which COVID-19 vaccine is most appropriate for their own situation.

Access the Fact Sheet for Healthcare Providers Administering Vaccine

Access the Fact Sheet for Recipients and Caregivers

Find more COVID related cardiovascular content

 


Related Content

News | Coronavirus (COVID-19)

May 31, 2023 — Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide. Depending on the geographical ...

Home May 31, 2023
Home
News | Coronavirus (COVID-19)

May 18, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), SARS ...

Home May 18, 2023
Home
News | Coronavirus (COVID-19)

May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy ...

Home May 10, 2023
Home
News | Coronavirus (COVID-19)

April 27, 2023 — New research suggests that even mild cases of COVID-19 can have long-term detrimental effects on ...

Home April 27, 2023
Home
News | Coronavirus (COVID-19)

April 27, 2023 — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has ...

Home April 27, 2023
Home
News | Coronavirus (COVID-19)

April 24, 2023 — Using powerful sequencing technology, researchers have identified specific biomarker patterns in the ...

Home April 24, 2023
Home
News | Coronavirus (COVID-19)

March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...

Home March 10, 2023
Home
News | Coronavirus (COVID-19)

March 3, 2023 — Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more ...

Home March 03, 2023
Home
News | Coronavirus (COVID-19)

February 21, 2023 — Analyzing the most extensive datasets in the United States, researchers from the Icahn School of ...

Home February 21, 2023
Home
News | Coronavirus (COVID-19)

January 6, 2023 — A study of children and adolescents who received a COVID-19 vaccination following multisystem ...

Home January 06, 2023
Home
Subscribe Now